S111: TREATMENT OF POST-TRANSPLANT RELAPSE IN CHILDREN, ADOLESCENTS AND YOUNG ADULTS WITH BCP ALL USING CD19-CAR-T: A EUROPEAN RETROSPECTIVE ANALYSIS OF REAL-WORLD DATA

• Peter Bader,
• Anna Alsonso,
• Andishe Attarbaschi,
• Nicole Bodmer,
• Halvard Bonig,
• Saskia Burridge,
• Jean-Pierre Bourquin,
• Veit Bücklein,
• Gunnar Cario,
• Macarena Oporto Espuelas,
• Tobias Feuhtinger,
• Anna Fuereder,
• Julia Hauer,
• Martin Hutter,
• Krzysztof Kałwak,
• Annette Künkele,
• Roland Meisel,
• Monika Mielcarek-Siedziuk,
• Ingo Müller,
• Sara Napolitano,
• Olaf Penack,
• Susana Rives,
• Claudia Rossig,
• Arend von Stackelberg,
• Andrea Jarisch,
• Sara Ghorashian,
• Adriana Balduzzi

Affiliations

Peter Bader

1 Goethe University, University Hospital, Department for Children and Adolescents, Division for Stern Cell Transplantation, Immunology and Intensive Care, Frankfurt, Frankfurt, Germany

Anna Alsonso

2 SJD Pediatric Cancer Center Barcelona, Barcelona, Spain

Andishe Attarbaschi

3 Vienna, Department of Pediatric Hematology and Oncology, St. Anna Children’s Hospital, Vienna, Austria

Nicole Bodmer

4 University Children’s Hospital Zürich, Zürich, Switzerland

Halvard Bonig

5 Goethe University Institute for Transfusion Medicine and lmmunohematology, Translational Development of Cellular Therapies, and German Red Cross Blood Service Baden-Württemberg–Hesse, Frankfurt, Germany

Saskia Burridge

6 Department of Haematology, Great Ormond Street Hospital for Children, London

Jean-Pierre Bourquin

4 University Children’s Hospital Zürich, Zürich, Switzerland

Veit Bücklein

7 Department of Medicine III, University Hospital, LMU Munich, München, Germany

Gunnar Cario

8 9Department of Pediatrics, University Medical Center Schleswig-Holstein, Campus Kiel, Germany, Kiel, Schleswig-Holstein, Kiel, Germany

Macarena Oporto Espuelas

9 UCL Great Ormond Street Institute of Child Health, London, United Kingdom

Tobias Feuhtinger

10 Department Pediatric Hematology, Oncology and Stern Cell Transplantation, Dr. von Hauner Children’s Hospital, LMU, Munich, München, Germany

Anna Fuereder

11 Department of Pediatric Hematology and Oncology, St. Anna Children’s Hospital, Medical University of Vienna, Vienna, Austria

Julia Hauer

12 Department of Pediatrics, Children’s Cancer Research Center, Kinderklinik München Schwabing, School of Medicine, Technical University of Munich, München, Germany

Martin Hutter

13 Goethe University, University Hospital, Department for Children and Adolescents, Division for Stern Cell Transplantation, Immunology and Intensive Care, Frankfurt, Germany

Krzysztof Kałwak

14 Clinical Department of Paediatric Bone Marrow Transplantation, Oncology and Haematology, Wroclaw Medical University, Supraregional Center of Pediatric Oncology “Cape of Hope”, 213 Borowska St. 50-556 Wroclaw, Wroclaw, Poland

Annette Künkele

15 Charite-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Department of Pediatric Oncology and Hematology, Berlin, Berlin, Germany

Roland Meisel

16 Division of Pediatric Stern Cell Therapy, Department of Pediatric Oncology, Hematology and Clinical lmmunology, Medical Faculty, Heinrich-Heine University, Duesseldorf, Düsseldorf, Germany

Monika Mielcarek-Siedziuk

14 Clinical Department of Paediatric Bone Marrow Transplantation, Oncology and Haematology, Wroclaw Medical University, Supraregional Center of Pediatric Oncology “Cape of Hope”, 213 Borowska St. 50-556 Wroclaw, Wroclaw, Poland

Ingo Müller

17 University Medical Center Hamburg-Eppendorf, Division of Pediatric Stern Cell Transplantation and Immunology, Hamburg, Hamburg, Germany

Sara Napolitano

18 Clinica Pediatrica Università degli Studi di Milano Bicocca, Fondazione IRCCS san Gerardo dei Tintori, Via Pergolesi 33, 20900 MONZA, Monza, Italy

Olaf Penack

19 Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Hematology, Oncology and Tumorimmunology, Augustenburger Platz 1, 13353 Berlin, Berlin, Germany

Susana Rives

20 CAR T-cell Unit. Pediatric Cancer Center Barcelona, Hospital Sant Joan de Déu de Barcelona, Barcelona, Spain

Claudia Rossig

21 Pediatric Hematology and Oncology, University Children’s Hospital Muenster, Muenster, Münster, Germany

Arend von Stackelberg

15 Charite-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Department of Pediatric Oncology and Hematology, Berlin, Berlin, Germany

Andrea Jarisch

1 Goethe University, University Hospital, Department for Children and Adolescents, Division for Stern Cell Transplantation, Immunology and Intensive Care, Frankfurt, Frankfurt, Germany

Sara Ghorashian

22 Department of Haematology, Great Ormond Street Hospital for Children, London, London, United Kingdom

Adriana Balduzzi

23 Clinica Pediatrica Università degli Studi di Milano Bicocca, Fondazione IRCCS san Gerardo dei Tintori, Via Pergolesi 33, 20900 MONZA, Monza, Italy